UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

DDX3 DEAD-box RNA helicase is a host factor that restricts hepatitis B virus replication at the transcriptional level

Journal of virology, 2014-12, Vol.88 (23), p.13689-13698

2014

Volltextzugriff (PDF)

Virucidal Activity of World Health Organization–Recommended Formulations Against Enveloped Viruses, Including Zika, Ebola, and Emerging Coronaviruses

The Journal of infectious diseases, 2017-03, Vol.215 (6), p.902-906

2017

Volltextzugriff (PDF)

A multicellular liver organoid model for investigating hepatitis C virus infection and nonalcoholic fatty liver disease progression

Hepatology (Baltimore, Md.), 2024-07, Vol.80 (1), p.186

2024

Volltextzugriff (PDF)

Identification of type I and type II interferon-induced effectors controlling hepatitis C virus replication

Hepatology (Baltimore, Md.), 2012-12, Vol.56 (6), p.2082-2093

2012

Volltextzugriff (PDF)

Novel Antiviral Activities of Obatoclax, Emetine, Niclosamide, Brequinar, and Homoharringtonine

Viruses, 2019-10, Vol.11 (10), p.964

2019

Volltextzugriff (PDF)

Optimization of BRET saturation assays for robust and sensitive cytosolic protein-protein interaction studies

Scientific reports, 2022-06, Vol.12 (1), p.9987-9987, Article 9987

2022

Volltextzugriff (PDF)

Benzimidazole Derivatives as Novel Zika Virus Inhibitors

ChemMedChem, 2020-08, Vol.15 (15), p.1453-1463

2020

Volltextzugriff (PDF)

Design of a multi-epitope Zika virus vaccine candidate - an in-silico study

Journal of biomolecular structure & dynamics, 2023-06, Vol.41 (9), p.3762-3771

2023

Volltextzugriff (PDF)

In Silico Design and Experimental Validation of siRNAs Targeting Conserved Regions of Multiple Hepatitis C Virus Genotypes

PloS one, 2016-07, Vol.11 (7), p.e0159211-e0159211

2016

Volltextzugriff (PDF)

DDX60L Is an Interferon-Stimulated Gene Product Restricting Hepatitis C Virus Replication in Cell Culture

Journal of virology, 2015-10, Vol.89 (20), p.10548-10568

2015

Volltextzugriff (PDF)

Nanobodies: an unexplored opportunity to combat COVID-19

Journal of biomolecular structure & dynamics, 2022-05, Vol.40 (7), p.3129-3131

2022

Volltextzugriff (PDF)

Determination of infectious hepatitis B virus particles by an end-point dilution assay identifies a novel class of inhibitors

Antiviral research, 2021-12, Vol.196, p.105195-105195, Article 105195

2021

Volltextzugriff (PDF)

Drug repurposing through virtual screening and in vitro validation identifies tigecycline as a novel putative HCV polymerase inhibitor

Virology (New York, N.Y.), 2022-05, Vol.570, p.9-17

2022

Volltextzugriff (PDF)

Common Nodes of Virus-Host Interaction Revealed Through an Integrated Network Analysis

Frontiers in immunology, 2019-10, Vol.10, p.2186-2186

2019

Volltextzugriff (PDF)

A Simple and Cost-Effective DNA Preparation Method Suitable for High-Throughput PCR Quantification of Hepatitis B Virus Genomes

Viruses, 2020-08, Vol.12 (9), p.928

2020

Volltextzugriff (PDF)

Screening of FDA-Approved Drugs Using a MERS-CoV Clinical Isolate from South Korea Identifies Potential Therapeutic Options for COVID-19

Viruses, 2021-04, Vol.13 (4), p.651

2021

Volltextzugriff (PDF)

Identification and Tracking of Antiviral Drug Combinations

Viruses, 2020-10, Vol.12 (10), p.1178

2020

Volltextzugriff (PDF)

Mouse Hepatic Cells Support Assembly of Infectious Hepatitis C Virus Particles

Gastroenterology (New York, N.Y. 1943), 2011-09, Vol.141 (3), p.1057-1066

2011

Volltextzugriff (PDF)

High Environmental Stability of Hepatitis B Virus and Inactivation Requirements for Chemical Biocides

The Journal of infectious diseases, 2019-03, Vol.219 (7), p.1044-1048

2019

Volltextzugriff (PDF)

The FDA-approved drug irbesartan inhibits HBV-infection in HepG2 cells stably expressing sodium taurocholate co-transporting polypeptide

Antiviral therapy, 2015-01, Vol.20 (8), p.835-842

2015

Volltextzugriff (PDF)

An Integrative Gene Expression Microarray Meta-analysis Identifies Host Factors and Key Signatures Involved in Hepatitis B Virus Infection

Infectious disorders drug targets, 2020, Vol.20 (5), p.698-707

2020

Volltextzugriff (PDF)

High tolerance of hepatitis B virus to thermal disinfection

Journal of hepatology, 2019-12, Vol.71 (6), p.1249-1251

2019

Volltextzugriff (PDF)

Suppression of Hepatitis C Virus Genome Replication and Particle Production by a Novel Diacylglycerol Acyltransferases Inhibitor

Molecules (Basel, Switzerland), 2018-08, Vol.23 (8), p.2083

2018

Volltextzugriff (PDF)

Molecular basis of the interaction of the human tyrosine phosphatase PTPN3 with the hepatitis B virus core protein

Scientific reports, 2021-01, Vol.11 (1), p.944-944, Article 944

2021

Volltextzugriff (PDF)

1 – 25 von 102

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(93)
Mit Volltextzugriff
(84)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

DDX3 DEAD-box RNA helicase is a host factor that restricts hepatitis B virus replication at the transcriptional level

Virucidal Activity of World Health Organization–Recommended Formulations Against Enveloped Viruses, Including Zika, Ebola, and Emerging Coronaviruses

A multicellular liver organoid model for investigating hepatitis C virus infection and nonalcoholic fatty liver disease progression

Identification of type I and type II interferon-induced effectors controlling hepatitis C virus replication

Novel Antiviral Activities of Obatoclax, Emetine, Niclosamide, Brequinar, and Homoharringtonine

Optimization of BRET saturation assays for robust and sensitive cytosolic protein-protein interaction studies

Benzimidazole Derivatives as Novel Zika Virus Inhibitors

Design of a multi-epitope Zika virus vaccine candidate - an in-silico study

In Silico Design and Experimental Validation of siRNAs Targeting Conserved Regions of Multiple Hepatitis C Virus Genotypes

DDX60L Is an Interferon-Stimulated Gene Product Restricting Hepatitis C Virus Replication in Cell Culture

Nanobodies: an unexplored opportunity to combat COVID-19

Determination of infectious hepatitis B virus particles by an end-point dilution assay identifies a novel class of inhibitors

Drug repurposing through virtual screening and in vitro validation identifies tigecycline as a novel putative HCV polymerase inhibitor

Common Nodes of Virus-Host Interaction Revealed Through an Integrated Network Analysis

A Simple and Cost-Effective DNA Preparation Method Suitable for High-Throughput PCR Quantification of Hepatitis B Virus Genomes

Screening of FDA-Approved Drugs Using a MERS-CoV Clinical Isolate from South Korea Identifies Potential Therapeutic Options for COVID-19

Identification and Tracking of Antiviral Drug Combinations

Mouse Hepatic Cells Support Assembly of Infectious Hepatitis C Virus Particles

High Environmental Stability of Hepatitis B Virus and Inactivation Requirements for Chemical Biocides

The FDA-approved drug irbesartan inhibits HBV-infection in HepG2 cells stably expressing sodium taurocholate co-transporting polypeptide

An Integrative Gene Expression Microarray Meta-analysis Identifies Host Factors and Key Signatures Involved in Hepatitis B Virus Infection

High tolerance of hepatitis B virus to thermal disinfection

Suppression of Hepatitis C Virus Genome Replication and Particle Production by a Novel Diacylglycerol Acyltransferases Inhibitor

Molecular basis of the interaction of the human tyrosine phosphatase PTPN3 with the hepatitis B virus core protein

Synergistic Interferon-Alpha-Based Combinations for Treatment of SARS-CoV-2 and Other Viral Infections

Suchergebnisse filtern